Sagitta Biotech
La probabilité de faillite calculée de Sagitta Biotech sur 12 mois est de 0,7% (faible). L'entreprise est active depuis 2019 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 7 ans |
| Direction | 2 |
| Sites | 1 |
| Publications | 15 |
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2025 | micro | 26-03-2026 | 2026-00064529 |
| 31-12-2024 | micro | 31-03-2025 | 2025-00060600 |
| 31-12-2023 | micro | 03-04-2024 | 2024-00057308 |
| 31-12-2022 | micro | 21-03-2023 | 2023-00044166 |
| 31-12-2021 | micro | 19-04-2022 | 2022-20005888 |
| 31-12-2020 | micro | 18-03-2021 | 2021-07900155 |
| 31-12-2019 | micro | 24-03-2020 | 2020-07400376 |
-
Actif18-01-2023 → auj.
-
NOSHAQ PARTNERSPersonne moraleAdministrateur· repr. perm.: SCHYNTS FrédéricActe Moniteur 23305887 (18-01-2023)Actif18-01-2023 → auj.
Anciens dirigeants (1)
-
NEMESIS CONSULTINGPersonne moraleAdministrateur· repr. perm.: DAMIEN BenjaminActe Moniteur 23305887 (18-01-2023)Ancien— → 18-01-2023
| NACE primaire | 72101 |
| Forme juridique | SA(014) |
| Date de constitution | 04-04-2019 |
| Status | Actif |
| Code postal | 4000 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 62002C0005/00X010 | Wallonie | 1 679 m² | — | — |
| 62826D0504/00C003 | Wallonie | 955 m² | 1 · 540 m² | 21,4 m · 7 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
23-04-2026 Réduction de capital de 750.000 € à 1.020.000 €
- €1.770.000 → €1.020.000
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1770000.0,
"delta_eur": 500000.0,
"before_eur": 1270000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "B",
"n_new_shares": 142,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3521.13
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 500000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 1020000.0,
"delta_eur": -750000.0,
"before_eur": 1770000.0,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-04-23",
"filing_date": "2026-04-21",
"act_kind_objet": "Objet de l\u0027acte : SIEGE SOCIAL, CAPITAL, ACTIONS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2026-04-21",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition de l\u2019assembl\u00E9e comprenant les procurations et le rapport du CA",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 114,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 482,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}23-04-2026 Transfert du siège social au sein de Liège
- Avenue du Pré-Aily, 10 4031 Liège (Angleur) → 4000 Liège, Avenue Hippocrate, 5, Bâtiment GIGA Entreprises.
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "4000 Li\u00E8ge, Avenue Hippocrate, 5, B\u00E2timent GIGA Entreprises.",
"city": "Li\u00E8ge",
"region": "waals_gewest",
"street": "Avenue Hippocrate",
"country": "BE",
"postcode": "4000",
"box_number": null,
"street_number": "5",
"locality_suffix": null
},
"old_address": {
"raw": "Avenue du Pr\u00E9-Aily, 10\n4031 Li\u00E8ge (Angleur)",
"city": "Li\u00E8ge",
"region": "waals_gewest",
"street": "Avenue du Pr\u00E9-Aily",
"country": "BE",
"postcode": "4031",
"box_number": null,
"street_number": "10",
"locality_suffix": "(Angleur)"
},
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": null,
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-04-23",
"filing_date": "2026-04-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2026-04-21",
"unanimous": null
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Geoffrey GAUTHY",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et le rapport du CA.",
"la coordination des statuts."
]
}01-08-2025 Augmentation de capital de 300.000 € à 1.270.000 €
- €970.000 → €1.270.000
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 300000.0,
"currency": "EUR",
"after_eur": 1270000.0,
"delta_eur": 300000.0,
"before_eur": 970000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-07-30",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 300.000,00 \u20AC pour le porter de 970.000,00 \u20AC \u00E0 1.270.000,00 \u20AC par la cr\u00E9ation de 84 actions de classe B nouvelles sans d\u00E9signation de valeur nominale, \u00E0 souscrire en num\u00E9raire au prix arrondi de 3.571,43 \u20AC par action, et \u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par les souscripteurs.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SA"
}
}01-08-2025 Augmentation de capital de 300.000 € à 1.270.000 €
- €970.000 → €1.270.000
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1270000.0,
"delta_eur": 300000.0,
"before_eur": 970000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "B",
"n_new_shares": 84,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3571.43
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 300000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-08-01",
"filing_date": "2025-07-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-07-30",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition de l\u2019assembl\u00E9e comprenant les procurations et le rapport du CA",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 114,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 340,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}12-03-2025 Augmentation de capital de 300.000 € à 970.000 €
- €670.000 → €970.000
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 300000.0,
"currency": "EUR",
"after_eur": 970000.0,
"delta_eur": 300000.0,
"before_eur": 670000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-02-27",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 300.000,00 \u20AC pour le porter de 670.000,00 \u20AC \u00E0 970.000,00 \u20AC par la cr\u00E9ation de 86 actions de classe B nouvelles sans d\u00E9signation de valeur nominale, \u00E0 souscrire en num\u00E9raire au prix arrondi de 3.488,37 \u20AC par action, et \u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par les souscripteurs.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SA"
}
}12-03-2025 Augmentation de capital de 300.000 € à 970.000 €
- €670.000 → €970.000
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 970000.0,
"delta_eur": 300000.0,
"before_eur": 670000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "B",
"n_new_shares": 86,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3488.37
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 300000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Benoit ROLANS",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-03-12",
"filing_date": "2025-03-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-02-27",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-02-27"
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et le rapport du CA",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 114,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 256,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}12-03-2025 Modification des statuts — traduction des statuts, coordination des statuts et modification d'articles spécifiques
Détails techniques
{
"notary": {
"name": "Benoit ROLANS",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-03-12",
"filing_date": "2025-03-10",
"act_kind_objet": "DIVERS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-02-27",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "translation_only",
"trigger": "capital_change_consequence",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0724.569.610",
"name_full_after": "SAGITTA BIOTECH",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "SAGITTA BIOTECH",
"current_zetel_raw": "Avenue Pr\u00E9-Aily 10 : 4031 Li\u00E8ge",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "Le capital est fix\u00E9 \u00E0 970.000,00 \u20AC et divis\u00E9 en 370 actions sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune un/trois cent septanti\u00E8me de l\u0027avoir social.",
"new_text": "Le capital est fix\u00E9 \u00E0 neuf cent septante mille euros (970.000,00 \u20AC). Il est divis\u00E9 en trois cent septante (370) actions, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune un/trois cent septanti\u00E8me (1/370\u00E8me) de l\u0027avoir social. Les trois cent septante (370) actions sont r\u00E9parties en 114 actions de classe A et 256 actions de classe B. Les actions des diff\u00E9rentes classes jouissent des m\u00EAmes d",
"change_kind": "amended",
"article_title": null,
"article_number": "5"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Benoit ROLANS",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et le rapport du CA",
"la coordination des statuts"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 370,
"shares_before": 370,
"capital_after_eur": 970000.0,
"capital_before_eur": 670000.0,
"share_classes_after": [
{
"count": 114,
"label": "classe A",
"rights_summary": "Les actions des diff\u00E9rentes classes jouissent des m\u00EAmes droits, sauf ce qui est pr\u00E9vu aux pr\u00E9sents statuts.",
"voting_per_share": null
},
{
"count": 256,
"label": "classe B",
"rights_summary": "Les actions des diff\u00E9rentes classes jouissent des m\u00EAmes droits, sauf ce qui est pr\u00E9vu aux pr\u00E9sents statuts.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}12-03-2025 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-02-27",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-01-2023 Transfert du siège social de Manage à Herstal
- Place Albert Ier 5, 7170 Manage → Hoyoux 87, Herstal
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Herstal",
"region": "R\u00E9gion Wallonne",
"street": "Hoyoux",
"country": "BE",
"postcode": null,
"box_number": null,
"street_number": "87"
},
"old_address": {
"city": "Manage",
"region": null,
"street": "Place Albert Ier",
"country": "BE",
"postcode": "7170",
"box_number": null,
"street_number": "5"
},
"effective_date": "2023-01-16",
"evidence_quote": "ARTICLE 2 - SIEGE Le si\u00E8ge est \u00E9tabli en Province de Li\u00E8ge (R\u00E9gion Wallonne). L\u2019adresse du si\u00E8ge peut \u00EAtre fix\u00E9e partout en Province de Li\u00E8ge sur simple d\u00E9cision du conseil d\u0027administration \u00E0 publier aux Annexes du Moniteur Belge."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SPRL"
}
}18-01-2023 Augmentation de capital de 650.000 € à 670.000 €
- €20.000 → €670.000
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 670000.0,
"delta_eur": 650000.0,
"before_eur": 20000.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 184,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3532.61
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 325000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 184,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-01-18",
"filing_date": "2023-01-16",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-01-16",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "REWISE AD",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Axel DUMONT"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SRL",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"rapport de l\u2019organe d\u2019administration",
"\u00E9tat r\u00E9sumant la situation active et passive",
"rapport du r\u00E9viseur",
"attestation bancaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 114,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 170,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}18-01-2023 4 administrateurs nommés, 1 démissionnaire
- DAMIEN Benjamin Claude — Bestuurder
- ALLAER Didier — Bestuurder
- SCHYNTS Frédéric — Bestuurder
- DAMIEN Benjamin Claude — Gedelegeerd bestuurder
- DAMIEN Benjamin — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DAMIEN Benjamin",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "NEMESIS CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u2019assembl\u00E9e accepte la d\u00E9mission de l\u2019administrateur unique, en raison de la transformation de la soci\u00E9t\u00E9 en SA, \u00E0 savoir la soci\u00E9t\u00E9 anonyme de droit luxembourgeois \u00AB NEMESIS CONSULTING \u00BB dont le repr\u00E9sentant permanent est Monsieur DAMIEN Benjamin."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DAMIEN Benjamin Claude",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0723853095",
"name": "NEMESIS CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe A, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : - La soci\u00E9t\u00E9 anonyme de droit luxembourgeois \u00AB NEMESIS CONSULTING \u00BB ayant son si\u00E8ge social \u00E0 (L-1471) Luxembourg, route d\u2019Esch 278 (Grand-Duch\u00E9 de Luxembourg), inscrite au reg"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ALLAER Didier",
"address": null,
"birth_date": null
},
"evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe B, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : - Monsieur ALLAER Didier, n\u00E9 \u00E0 Cologne le 18 d\u00E9cembre 1961, domicili\u00E9 \u00E0 4530 Villers-le-Bouillet, rue les Waleffes, 1"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SCHYNTS Fr\u00E9d\u00E9ric",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0808219836",
"name": "NOSHAQ PARTNERS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe B, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : ... - La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB NOSHAQ PARTNERS \u00BB, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, rue Lambert Lombard, 3. T.V.A. num\u00E9ro 0808.219.836. RPM Li\u00E8ge (division Li\u00E8ge), do"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "DAMIEN Benjamin Claude",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0723853095",
"name": "NEMESIS CONSULTING",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Conform\u00E9ment aux statuts, le conseil d\u0027administration d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de d\u00E9l\u00E9guer la gestion journali\u00E8re des affaires de la soci\u00E9t\u00E9 ainsi que la repr\u00E9sentation pour cette gestion \u00E0 la soci\u00E9t\u00E9 anonyme de droit luxembourgeois \u00AB NEMESIS CONSULTING \u00BB dont le repr\u00E9sentant permanent est Monsieur DAMI"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SPRL"
}
}18-01-2023 4 administrateurs nommés
- DAMIEN Benjamin Claude — Directeur
- ALLAER Didier — Directeur
- SCHYNTS Frédéric — Directeur
- DAMIEN Benjamin — Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "DAMIEN Benjamin Claude",
"address": "1653 Luxembourg (Grand-Duch\u00E9 de Luxembourg), rue du Fort Elisabeth, 29",
"birth_date": "1973-06-27",
"profession": null,
"birth_place": "La Hestre"
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "NEMESIS CONSULTING",
"address": "route d\u2019Esch 278",
"country": "LU",
"legal_form": "SA"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "ALLAER Didier",
"address": "4530 Villers-le-Bouillet, rue les Waleffes, 1",
"birth_date": "1961-12-18",
"profession": null,
"birth_place": "Cologne"
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "SCHYNTS Fr\u00E9d\u00E9ric",
"address": "4000 Li\u00E8ge, rue du Calvaire 29",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "NOSHAQ PARTNERS",
"address": "4000 Li\u00E8ge, rue Lambert Lombard, 3",
"country": "BE",
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "DAMIEN Benjamin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "NEMESIS CONSULTING",
"address": null,
"country": "LU",
"legal_form": "SA"
},
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-01-18",
"filing_date": "2023-01-16",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-01-16",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean-Michel GAUTHY",
"org_rep_person_name": null,
"person_role_at_subject": "notaire associ\u00E9"
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant 2 procurations, 2 rapports de l\u2019organe d\u2019administration, le rapport du r\u00E9viseur et l\u2019attestation bancaire",
"la coordination des statuts"
],
"corrected_publication_numac": null
}18-01-2023 Augmentation de capital de 650.000 € à 670.000 €
- €20.000 → €670.000
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 650000.0,
"currency": "EUR",
"after_eur": 670000.0,
"delta_eur": 650000.0,
"before_eur": 20000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-01-16",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de six cent cinquante mille euros (650.000,00 \u20AC) pour le porter de vingt mille euros (20.000,00 \u20AC) \u00E0 six cent septante mille euros (670.000,00 \u20AC) par la cr\u00E9ation de 184 actions nouvelles sans d\u00E9signation de valeur nominale, \u00E0 souscrire en num\u00E9raire au prix arrondi de 3.532,61 \u20AC par action, et \u00E0 lib\u00E9rer \u00E0 concurrence de moiti\u00E9 par les souscripteurs.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SPRL"
}
}18-01-2023 Transfert du siège social
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "4031 Li\u00E8ge (Angleur), Avenue du Pr\u00E9-Aily, 10",
"city": null,
"region": null,
"street": null,
"country": "BE",
"postcode": null,
"box_number": null,
"street_number": null,
"locality_suffix": null
},
"old_address": {
"raw": "Place Albert Ier 5 : 7170 Manage",
"city": "Manage",
"region": "waals_gewest",
"street": "Place Albert Ier",
"country": "BE",
"postcode": "7170",
"box_number": null,
"street_number": "5",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY \u0026 JACQUES \u2013 Notaires Associ\u00E9s",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-01-18",
"filing_date": "2023-01-16",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-01-16",
"unanimous": true
},
"subject_company": {
"kbo": "0724.569.610",
"name_full": "SAGITTA BIOTECH",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant 2 procurations, 2 rapports de l\u2019organe d\u2019administration, le rapport du r\u00E9viseur et l\u2019attestation bancaire",
"la coordination des statuts"
]
}08-04-2019 Constitution d'une société (SNC)
Détails techniques
{
"kind": "oprichting",
"seat": "Place Albert Ier 5, 7170 Fayt-lez-Manage",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0723.853.095",
"name": "NEMESIS CONSULTING"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "nominative",
"partner_role": null,
"holder_org_kbo": "0723.853.095",
"holder_org_name": "NEMESIS CONSULTING",
"contribution_type": "cash",
"amount_paid_in_eur": 20000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 20000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 20000,
"subject_company": {
"kbo": "0724.569.610",
"name_full": "Sagitta Biotech",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2019-04-04",
"post_incorporation_mandates": []
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | Sagitta Biotech |